Ieq Capital LLC Takes Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Ieq Capital LLC acquired a new position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 29,436 shares of the biotechnology company’s stock, valued at approximately $221,000. Other institutional investors have also recently […]
